Signaling pathways
-
BA5702 TaprenepagSummary: Taprenepag (CP-544326) is a potent and selective prostaglandin agonist. - BA5703 KAG-308Summary: KAG-308 is a potent, selective, orally available (a prostaglandin E2 receptor subtype) agonist.
- BA5704 MF-766Summary: MF-766 is a potent, selective and orally active antagonist.
- BA5705 VidupiprantSummary: Vidupiprant (AMG853) is a phenylacetic acid derivative and a potent orally active and dual antagonist.
- BA5706 RidogrelSummary: Ridogrel (R68070) is an orally active thromboxane A2 synthase inhibitor and thromboxane A2/prostaglandin endoperoxide receptor blocker.
- BA5707 RalinepagSummary: Ralinepag is a potent, orally available, non-prostaglandin agonist.
- BA5708 EvatanepagSummary: Evatanepag (CP-533536) is a non-prostaglandin, potent and selective agonist.
- BA5709 PDC31Summary: PDC31 (THG113.31; ILGHXDYK) is a variant and noncompetitive inhibitor.
- BA5710 SetipiprantSummary: Setipiprant (ACT-129968) is an orally active, selective antagonist.
- BA5711 MK-7246Summary: MK-7246 is a potent and selective antagonist.